WuXi AppTec Co., Ltd. (SHA:603259)

China flag China · Delayed Price · Currency is CNY
98.68
+0.56 (0.57%)
Aug 14, 2025, 3:00 PM CST
138.47%
Market Cap 286.10B
Revenue (ttm) 41.48B
Net Income (ttm) 13.77B
Shares Out 2.92B
EPS (ttm) 4.01
PE Ratio 21.58
Forward PE 21.15
Dividend 0.98 (1.07%)
Ex-Dividend Date May 21, 2025
Volume 80,763,150
Average Volume 60,514,335
Open 99.00
Previous Close 98.12
Day's Range 97.30 - 102.36
52-Week Range 36.86 - 102.49
Beta 0.73
RSI 72.97
Earnings Date Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula... [Read more]

Sector Healthcare
Founded 2000
Employees 39,414
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603259
Full Company Profile

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial Statements

News

There is no news available yet.